Русский
English
عربي
Inspire Pharmaceutical Company
The company was founded in the early 1990s and headquartered in Durham, North Carolina, USA.
Inspire Pharmaceuticals specialized in creating novel therapies aimed at improving the quality of life for patients with chronic conditions. The company’s most notable contributions were in the areas of ocular (eye) health and respiratory care, with treatments targeting diseases like dry eye and cystic fibrosis.
Some key points about Inspire Pharmaceuticals include:
-
Ophthalmology — The company developed treatments for ocular diseases, most notably Restasis, a widely used prescription medication for dry eye disease.
-
Respiratory Disorders — Inspire Pharmaceuticals also worked on therapies for conditions such as cystic fibrosis, developing new medicines to treat respiratory issues.
-
Research and Development — The company was known for its strong focus on research and innovation in drug development, particularly in specialized areas like eye care and respiratory conditions.
In 2011, Inspire Pharmaceuticals was acquired by Astellas Pharma, a major global pharmaceutical company, which integrated Inspire’s research and development pipeline into its own portfolio. As a result, Inspire Pharmaceuticals ceased to operate as an independent entity, and its assets were absorbed into Astellas.
Brand products
